Trulieve Cannabis (TCNNF) Asset Writedowns and Impairment (2021 - 2024)

Trulieve Cannabis' Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $477000.0 for Q3 2024.

• In Q3 2024, Asset Writedowns and Impairment rose 139.45% year-over-year to $477000.0; the TTM figure through Sep 2024 stood at $2.2 million (up 105.53% YoY), while the FY2023 annual figure was $2.8 million, down 23.97% from the prior year.
• Asset Writedowns and Impairment was $477000.0 for Q3 2024 at Trulieve Cannabis, down from $5.8 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $54.6 million in Q3 2022 to a low of -$72.5 million in Q4 2022.
• Historically, Asset Writedowns and Impairment has averaged $1.7 million across 4 years, with a median of $42000.0 in 2022.
• Biggest YoY gain for Asset Writedowns and Impairment was 1092880.0% in 2022; the steepest drop was 1450860.0% in 2022.
• A 4-year view of Asset Writedowns and Impairment shows it stood at $5000.0 in 2021, then tumbled by 1450860.0% to -$72.5 million in 2022, then jumped by 96.24% to -$2.7 million in 2023, then soared by 117.47% to $477000.0 in 2024.
• The last three Asset Writedowns and Impairment figures came in at $477000.0 (Q3 2024), $5.8 million (Q2 2024), and -$1.4 million (Q1 2024), per Business Quant data.